Bone cement and cementation technique, antibiotics and bone cement spacers: what should you know?

Authors

  • Giovanni Calonego

DOI:

https://doi.org/10.15674/0030-59872013487-92

Keywords:

arthroplasty, cementing technique, antibiotics

Abstract

Analyzed cementing technique and implant design . It is shown that scientific and technological progress in the industry enables us to obtain 97% survival rate of implants 10 years after surgery. According to recent reports , infectious complications in 20% of cases the cause of revision cases . Using acrylic cement saturated antibiotics reduces the risk of infectious complications. Cement spacers allow to obtain a positive result in the case of chronic infection.

References

  1. Baleani M. The mechanical behaviour of a preformed hip spacer / M. Baleani, F. Traina, A. Toni // Hip International. — 2003. — Vol. 13. — P. 159–162.
  2. Effect of a centralizing device on cement mantle deficiencies and initial prosthetic alignment in total hip arthroplasty / R. A. Berger, M. J. Seel, K. Wood et al. // J. Arthroplasty. — 1997. — Vol. 12 (4). — P. 434–443.
  3. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty / E. Bertazzoni Minelli, A. Benini, B. Magnan, P. Bartolozzi // J. Antimicrob. Chemother. — 2004. — Vol. 53 (2). — P. 329–334.
  4. The epidemiology of revision total knee arthroplasty in the United States / K. J. Bozic, S. M. Kurtz, E. Lau et al. // Clin. Orthop. Relat. Res. — 2010. — Vol. 468 (1). — P. 45–51.
  5. Breusch S. The Well-Cemented Total Hip Arthroplasty. Theory and practice / S. Breusch, H. Malchau. — Springer Medizin Verlag Heidelberg, 2005. — 378 p.
  6. Management of deep infection of total hip replacement / H. W. Buchholz, R. A. Elson, E. Engelbrecht et al. // J. Bone Joint Surg. — 1981. — Vol. 63-B (3). — P. 342–353.
  7. Charnley J. The long-term results of low-friction arthroplasty of the hip performed as a primary intervention / J. Charnley // J. Bone Joint Surg. — 1972. — Vol. 54-B (1). — P. 61–76.
  8. Coffey M. J. Treatment of glenohumeral sepsis with a commercially produced antibiotic-impregnated cement spacer / M. J. Coffey, E. E. Ely, L. A. Crosby // J. Shoulder Elbow Surg. — 2010. — Vol. 19 (6). — P. 868–873.
  9. Less wear with aluminium-oxide heads than cobalt-chrome heads with ultra-high molecular weight cemented polyethylene cups: a ten-year follow-up with radiostereometry / J. Dahl, P. Söderlund, B. Nivbrant et al. // Int. Orthop. — 2012. — Vol. 36 (3). — P. 485–490.
  10. The use of a preformed spacer in two-stage revision of infected hip arthroplasties / F. D’Angelo, L. Negri, T. Binda et al. // Musculoskelet. Surg. — 2011. — Vol. 95 (2). — P. 115–120.
  11. Does a prefabricated gentamicin-impregnated, load-bearing spacer control periprosthetic hip infection? / R. M. Degen, J. R. Davey, J. R. Davey et al. // Clin. Orthop. Relat. Res. — 2012. — Vol. 470 (10). — P. 2724–2729.
  12. England, Wales & Northern Ireland National Joint Registry [electronic resource] — http://www-new.njrcentre.org.uk/njrcentre/Default.aspx.
  13. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995 / B. Espehaug, L. B. Engesaeter, S. E. Vollset et al. // J. Bone Joint Surg. — 1997. — Vol. 79-B (4). — P. 590–595.
  14. Radiological evaluation of acetabular erosion after antibiotic-impregnated polymethylmethacrylate spacer (Spacer-G) / E. García-Oltra, G. Bori, X. Tomas et al. // J. Arthroplasty. — 2013. — Vol. 28 (6). — P. 1021–1024.
  15. Two-stage revision of hip prosthesis infection using a hip spacer with stabilising proximal cementation / S. Gil Gonzalez, F. MarquésLópez, P. Rigol Ramon et al. // Hip Int. — 2010. — Vol. 20 (Suppl. 7). — P. S128–S134.
  16. A prospective randomized radiostereometric analysis trial of SmartSet HV and Palacos R bone cements in primary total hip arthroplasty / O. S. Husby, K. Haugan, P. Benum, O. A. Foss // J. Orthop. Traumatol. — 2010. — Vol. 11 (1). — Р. 29–35.
  17. Joseph T. N. Use of antibiotic-impregnated cement in total joint arthroplasty / T. N. Joseph, A. L. Chen, P. E. Di Cesare // J. Am. Acad. Orthop. Surg. — 2003. — Vol. 11 (1). — Р. 38–47.
  18. Complications after spacer implantation in the treatment of hip joint infections / J. Jung, N. V. Schmid, J. Kelm et al. // Int. J. Med. Sci. — 2009. — Vol. 6 (5). — Р. 265–273.
  19. Increased metal release from cemented femoral components made of titanium alloy. 19 hip prostheses followed with radiostereometry (RSA) / J. Kärrholm, W. Frech, K. G. Nilsson, F. Snorrason // Acta Orthop Scand. — 1994. — Vol. 65 (6). — Р. 599–604.
  20. Prosthetic joint infection risk after TKA in the Medicare population / S. M. Kurtz, K. L. Ong, E. Lau et al. // Clin. Orthop. Relat. Res. — 2010. — Vol. 468 (1). — Р. 52–56.
  21. Gait analysis in patients with a preformed articulated knee spacer / N. Logoluso, C. Champlon, G. Melegati et al. // Knee. — 2012. — Vol. 19 (4). — Р. 370–372.
  22. Vacuum-mixing significantly changes antibiotic elution characteristics of commercially available antibiotic-impregnated bone cements / J. Meyer, G. Piller, C. A. Spiegel et al. // J. Bone Joint. Surg. Am. — 2011. — Vol. 93 (22). Р. 2049–2056.
  23. Millennium Group Survey, 2011 — Global market for Large Joint Reconstruction.
  24. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers / D. J. Moojen, B. Hentenaar, H. Charles Vogely et al. // J. Arthroplasty. — 2008. — Vol. 23 (8). — Р. 1152–1156.
  25. Measurements of in vivo intra-articular gentamicin levels from antibiotic loaded articulating spacers in revision total knee replacement / J. Mutimer, G. Gillespie, A. M. Lovering, A. J. Porteous // Knee. — 2009. — Vol. 16 (1). — Р. 39–41.
  26. Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer / D. R. Neumann, T. Hofstaedter, C. List, U. Dorn // J. Arthroplasty. — 2012. — Vol. 27 (7). — Р. 1397–1401.
  27. Bone cement with reduced proportion of monomer in total hip arthroplasty: preclinical evaluation and randomized study of 47 cases with 5 years’ follow-up / B. Nivbrant, J. Kärrholm, S. Röhrl et al. // Acta Orthop. Scand. — 2001. — Vol. 72 (6). — Р. 572–584.
  28. Norwegian Arthroplasty Register http://nrlweb.ihelse.net/eng/default.htm.
  29. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population / K. L. Ong, S. M. Kurtz, E. Lau et al. // J. Arthroplasty. — 2009. — Vol. 24 (Suppl 6). — Р. 105–109.
  30. Preformed gentamicin spacers in two-stage revision hip arthroplasty: functional results and complications / C. Pattyn, T. De Geest, P. Ackerman, E. Audenaert // Int. Orthop. — 2011. — Vol. 35 (10). — Р. 1471–1476.
  31. Pre-formed articulating knee spacer in two-stage revision for the infected total knee arthroplasty / R. P. Pitto, C. C. Castelli, R. Ferrari, J. Munro // Int. Orthop. — 2005. — Vol. 29 (5). — Р. 305–308.
  32. Pitto R P. CEMEX®GENTA bone cement in total hip arthroplasty. Clinical outcome and Radiostereoanalysis of 25 hips with 2-year follow-up / R. P. Pitto, R. Schmidt // Clinical Report. — 2003.
  33. Pitto R. P. CEMEX®SYSTEM GENTA bone cement in total hip arthroplasty. Clinical outcome and Radiostereoanalysis. A 5-year follow-up / R. P. Pitto // Clinical Report. — 2007.
  34. Does cyclical loading affect the elution of antibiotics from articulating cement knee spacers? / B. A. Rogers, F. R. Middleton, N. Shearwood-Porter et al. // J. Bone Joint. Surg. Br. — 2011. — Vol. 93 (7). — Р. 914–920.
  35. Analysis of the gait in patients with hip spacers / C. L. Romanò, M. Ferrarin, M. Rabbuffetti et al. // Infection and local treatment in orthopedic surgery / E. Meani, C. Romanò, L. Crosby, G. Hoffman. — Springer-Verlag, February, 2007. — 587 p.
  36. Preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Long-term results / C. L. Romanò, D. Romanò, A. Albisetti, E. Meani // Hip Int. — 2012. — Vol. 22 (Suppl 8) — Р. S46–S53.
  37. Two-stage revision surgery with preformed spacers and cementless implants for septic hip arthritis: a prospective, non-randomized cohort study / C. L. Romanò, D. Romanò, E. Meani et al. // BMC Infect Dis. — 2011. — Vol. 11. — Р. 129.
  38. Scheerlinck T. The design features of cemented femoral hip implants / T. Scheerlinck, P. P. Casteleyn // J. Bone Joint. Surg. Br. — 2006. — Vol. 88 (11). — Р. 1409–1418.
  39. 10-year results of a new low-monomer cement: follow-up of a randomized RSA study / P. Söderlund, J. Dahl, S. Röhrl et al. // Acta. Orthop. — 2012. — Vol. 83 (6). — Р. 604–608.
  40. Premixed antibiotic bone cement: an in vitro comparison of antimicrobial efficacy / M. W. Squire, B. J. Ludwig, J. R. Thompson et al. // J. Arthroplasty. — 2008. — Vol. 23 (Suppl 1). — Р. 110–114.
  41. Swedish Hip Arthroplasty Register http://www.shpr.se/en/default.aspx.
  42. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release / H. van de Belt, D. Neut, D. R. Uges et al. // Biomaterials. — 2000. — Vol. 21 (19). — Р. 1981–1987.
  43. Villa T. Experimental evaluation of the biomechanical performances of a PMMA-based knee spacer / T. Villa, D. Carnelli // Knee. — 2007. — Vol. 14 (2). — Р. 145–153
  44. Preformed articulating knee spacers in 2-stage total knee revision arthroplasty: minimum 2-year follow-up / Z. Wan, A. Karim, A. Momaya et al. // J. Arthroplasty. — 2012. — Vol. 27 (8). — Р. 1469–1473.

Downloads

How to Cite

Calonego, G. (2014). Bone cement and cementation technique, antibiotics and bone cement spacers: what should you know?. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (4), 87–92. https://doi.org/10.15674/0030-59872013487-92

Issue

No. 4 (2013)

Section

IN AID OF PRACTING DOCTOR. LECTURES

License

Copyright (c) 2014 Giovanni Calonego

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).